Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: J Immunol. 2015 Apr 24;194(11):5329–5345. doi: 10.4049/jimmunol.1400854

Table 1. HLA-B*42:01 associations with IFNγOLP responses (n=1,009).

Protein-OLP Sequence OLP Optimal Epitope HXB2 Q-valued Reference
Gag-3 EKIRLRPGGKKHYMLKHL RPGGKKHYMa Gag-RM9 Gag(22-30) ns This study
Gag-20 QMVHQAISPRTLNAWVKV SPRTLNAWVb Gag-SV9 Gag(148-156) ns This study
Gag-25 GATPQDLNTMLNTVGGH TPQDLNTML Gag-TL9 Gag(180-188) 1.28E-124 Llano 2008
Gag-37 WIILGLNKIVRMYSPVSIc no no no 1.28E-02 This study
Gag-48 ACQGVGGPSHKARVLAEA GPSHKARVL Gag-GL9 Gag(355-363) ns Llano 2008
Gag-52 QRSNFKGPKRIVKCF GPKRIVKCFb Gag-GF9 Gag(386-394) 8.25E-03 This study
RT-184 PSINNETPGIRYQYNVL TPGIRYQYNVLb RT-TL11 Pol(294-304) 2.01E-12 This study
RT-186 QYNVLPQGWKGSPAIF LPQGWKGSPAIb RT-LI11 Pol(304-314) 3.90E-02 This study
RT-187 QGWKGSPAIFQSSMTKIL SPAIFQSSMb RT-SM9 Pol(311-319) ns This study
RT-202 SKLNWASQIYPGIKVRQL YPGIKVRQL RT-YL9 Pol(426-434) 7.17E-09 Llano 2008
Int-244 MASEFNLPPIVAKEIVA LPPIVAKEI Int-LI9 Pol(743-751) 5.04E-49 Llano 2008
Int-275 KVVPRRKAKIIKDYGKQM IIKDYGKQMa Int-IM9 Pol(982-990) 1.48E-98 This study
Nef-73 GALTSSNTDTTNADCAWLc no no no 3.45E-02 This study
Nef-76 EVGFPVRPQVPLRPMTFK RPQVPLRPM Nef-RM9 Nef(71-79) 8.24E-17 Llano 2008
Nef-78 FKGAFDLSFFLKEKGGLc no no no 9.15E-03 This study
Nef-84 NYTPGPGVRYPLTFGWCF TPGPGVRYPL Nef-TL10 Nef(382-411) 3.26E-16 Llano 2008
Vpr-281 ELKQEAVRHFPRPWLHGL FPRPWLHGL Vpr-FL9 Vpr(34-42) 1.61E-70 Llano 2008
Vif-407 RHHYESRHPKVSSEVHI HPKVSSEVHIa Vif-HI10 Vif(48-57) 7.97E-69 This study
Env-328 VCTRPNNNTRKSIRI RPNNNTRKSIb Env-RI10 Env(298-307) 2.24E-03 This study
Env-401 NIPRRIRQGFEAALL IPRRIRQGFa Env-IF9 Env(843-851) ns This study
a

New optimal epitope (not listed in Los Alamos ‘A’ List Database) defined in this study.

b

New optimal epitope (not listed in Los Alamos ‘A’ List Database) not defined in this study.

c

Optimal epitope not identified within the OLP sequence.

d

q-values for associations between HLA-B*42:01 expression (n=181) and OLP responses computed from analysis of IFNγ ELISpot data across 1,009 subjects. no, not optimized; ns, not significant.